Pasqal’s $2bn Nasdaq Bet Comes With a French Veto
France’s Pasqal, a leading neutral-atom quantum company, is set to list on Nasdaq via a Special Purpose Acquisition Company (SPAC) at a staggering $2bn valuation—approximately 100 times its 2025 revenue. Its SPAC filings provide candid insights: commercial quantum computing may never materialize, and foreign investors seeking significant stakes must gain approval from the French government.
Key Takeaways:
- Valuation: Pasqal’s $2bn valuation is roughly 100 times its reported $16.5m revenue in 2025.
- Market Comparison: While this appears high, it pales in comparison to listed peers like Quantinuum, valued at around $20bn, or about 647 times their revenue.
- Quantum Gamble: Filings warn that "commercial traction of quantum computing technology may never occur," highlighting the significant risk involved.
- French Influence: As a French company working on strategic tech, Pasqal faces French state influence, allowing Paris to vet foreign or non-EU investors with substantial stakes.
- Strategic Listing: The company chose the US for its depth of capital, following a trend of European deep-tech firms crossing the Atlantic.
- Deal Details: The combined entity, Pasqal Holding SA, expects $500m in gross proceeds from the offering and aims to close on Nasdaq in Q3 2026.
The listing underscores Europe’s dual desire to nurture tech champions while maintaining control over strategic sectors.